tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CPRX Stock Latest News

Catalyst Pharma Patent Trial Against Hetero USA Delayed
Company AnnouncementsCatalyst Pharma Patent Trial Against Hetero USA Delayed
2d ago
8K
CPRX
Catalyst Pharmaceutical Partners Signals Confident Growth Path
PremiumCompany Announcements
Catalyst Pharmaceutical Partners Signals Confident Growth Path
11d ago
CPRX
Buy Rating on Catalyst Pharma Driven by Strong 2026 Growth Outlook and Favorable Firdapse Litigation Upside
PremiumRatings
Buy Rating on Catalyst Pharma Driven by Strong 2026 Growth Outlook and Favorable Firdapse Litigation Upside
17d ago
CPRX
Catalyst Pharmaceuticals price target raised to $35 from $33 at Citi
PremiumThe Fly
Catalyst Pharmaceuticals price target raised to $35 from $33 at Citi
17d ago
CPRX
Buy Rating on Catalyst Pharma Backed by Strong Growth, Underpenetrated LEMS Opportunity, and Rising Profitability Post-Royalty Roll-Off
PremiumRatings
Buy Rating on Catalyst Pharma Backed by Strong Growth, Underpenetrated LEMS Opportunity, and Rising Profitability Post-Royalty Roll-Off
18d ago
CPRX
Catalyst Pharma Posts Record 2025 Results, Raises 2026 Outlook
PremiumCompany AnnouncementsCatalyst Pharma Posts Record 2025 Results, Raises 2026 Outlook
23d ago
8K
CPRX
Catalyst Pharmaceuticals reports Q4 EPS 68c, consensus 50c
Premium
The Fly
Catalyst Pharmaceuticals reports Q4 EPS 68c, consensus 50c
23d ago
CPRX
Catalyst Pharmaceuticals sees FY26 revenue $615M-$645M, consensus $615.58M
Premium
The Fly
Catalyst Pharmaceuticals sees FY26 revenue $615M-$645M, consensus $615.58M
23d ago
CPRX
Is CPRX a Buy, Before Earnings?
PremiumPre-Earnings
Is CPRX a Buy, Before Earnings?
25d ago
CPRX
Catalyst Pharmaceuticals: Rare-Disease Buy-and-Build Strategy, Strong Launches, and Capital Flexibility Underpin Buy Rating
PremiumRatings
Catalyst Pharmaceuticals: Rare-Disease Buy-and-Build Strategy, Strong Launches, and Capital Flexibility Underpin Buy Rating
2M ago
CPRX
Catalyst Pharma Highlights Growth Strategy at J.P. Morgan Conference
PremiumCompany Announcements
Catalyst Pharma Highlights Growth Strategy at J.P. Morgan Conference
2M ago
8K
CPRX
Catalyst Pharmaceuticals Reports Strong Q3 2025 Earnings
PremiumCompany Announcements
Catalyst Pharmaceuticals Reports Strong Q3 2025 Earnings
4M ago
CPRX
Catalyst Pharma’s Strategic Growth and Market Positioning: A Promising Outlook
PremiumRatingsCatalyst Pharma’s Strategic Growth and Market Positioning: A Promising Outlook
4M ago
CPRX
Catalyst Pharmaceuticals price target raised to $33 from $32 at Oppenheimer
Premium
The Fly
Catalyst Pharmaceuticals price target raised to $33 from $32 at Oppenheimer
4M ago
CPRX
Catalyst Pharmaceuticals price target raised to $33 from $31 at Citi
Premium
The Fly
Catalyst Pharmaceuticals price target raised to $33 from $31 at Citi
4M ago
CPRX
Catalyst Pharmaceuticals Reports Strong Q3 2025 Results
PremiumCompany Announcements
Catalyst Pharmaceuticals Reports Strong Q3 2025 Results
4M ago
CPRX
Catalyst Pharmaceuticals reports Q3 EPS 68c, consensus 54c
PremiumThe Fly
Catalyst Pharmaceuticals reports Q3 EPS 68c, consensus 54c
4M ago
CPRX
Catalyst Pharma Reports Strong Q3 2025 Financial Results
PremiumCompany Announcements
Catalyst Pharma Reports Strong Q3 2025 Financial Results
4M ago
8K
CPRX
Is CPRX a Buy, Before Earnings?
PremiumPre-Earnings
Is CPRX a Buy, Before Earnings?
5M ago
CPRX
Catalyst Pharma Announces $200M Share Repurchase Program
PremiumCompany AnnouncementsCatalyst Pharma Announces $200M Share Repurchase Program
6M ago
8K
CPRX
Nike reports Q1 beat, U.S. takes 5% stake in Lithium Americas: Morning Buzz
Premium
The Fly
Nike reports Q1 beat, U.S. takes 5% stake in Lithium Americas: Morning Buzz
6M ago
F
AES
Catalyst Pharmaceuticals announces $200M share repurchase program
Premium
The Fly
Catalyst Pharmaceuticals announces $200M share repurchase program
6M ago
CPRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >